In particular, NHL subtypes including Immunoblastic lymphomas and PCNSL, along with Burkitt’s-like lymphomas, typically develop in patients with very low CD4+ T-cell counts. This evidence concerns the gene CD4 and non-Hodgkin lymphoma.